Advertisement
Screener

INTERPACE BIOSCIENCES, INC. (IDXGD) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

INTERPACE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

INTERPACE BIOSCIENCES, INC. (IDXGD) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 1.75% for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2024-04-01

  • INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-03-31 was 1.75%, a 0.57% decline year-over-year.
  • INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2022-03-31 was 1.76%, a 125.64% increase year-over-year.
  • INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2021-03-31 was 0.78%, a 48.34% decline year-over-year.
  • INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2020-03-31 was 1.51%, a 39.84% decline year-over-year.
  • INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 1.75%, a 121.52% increase from fiscal 2021.
  • INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 0.79%, a 5.33% increase from fiscal 2020.
  • INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2020 was 0.75%, a 67.95% decline from fiscal 2019.
  • INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2019 was 2.34%, a 13.65% decline from fiscal 2018.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month as first filed
2023-09-301.75%
10-Q · filed 2023-11-08
2023-06-301.75%
10-Q · filed 2023-08-09
2023-03-311.75%
10-Q · filed 2023-05-12
2022-12-311.75%
10-K · filed 2024-04-01
2022-09-301.76%
10-Q · filed 2022-11-14
2022-06-301.76%
10-Q · filed 2022-08-15
2022-03-311.76%
10-Q · filed 2022-05-16
2021-12-310.79%
10-K · filed 2023-03-27
2021-09-300.78%
10-Q · filed 2022-11-14
2021-06-300.78%
10-Q · filed 2022-08-15
2021-03-310.78%
10-Q · filed 2022-05-16
2020-12-310.75%
10-K · filed 2022-03-31
2020-09-300.79%
10-Q · filed 2021-11-10
2020-06-301.20%
10-Q · filed 2021-08-11
2020-03-311.51%
10-Q · filed 2021-05-11
2019-12-312.34%
10-K · filed 2021-04-01
2019-09-302.51%
10-Q · filed 2021-01-20
2019-06-302.51%
10-Q/A · filed 2021-01-19
2019-03-312.51%
10-Q/A · filed 2021-01-19
2018-12-312.71%
10-K/A · filed 2021-01-19
2018-09-302.65%
10-Q · filed 2019-11-14
2018-06-302.65%
10-Q · filed 2019-08-13
2018-03-312.65%
10-Q · filed 2019-05-14
2017-12-311.85%
10-K · filed 2019-03-21
2017-09-301.85%
10-Q · filed 2018-11-14
2017-06-301.96%
10-Q · filed 2018-08-09
2017-03-311.96%
10-Q · filed 2018-05-15
2016-12-310.66%
10-K · filed 2018-03-23
2015-12-311.02%
10-K · filed 2017-03-31
2015-09-301.02%
10-Q · filed 2016-11-17
2015-06-301.02%
10-Q · filed 2016-08-15
2015-03-310.97%
10-Q · filed 2016-05-12
2014-12-310.75%
10-K · filed 2016-03-30
2014-09-300.71%
10-Q · filed 2015-11-12
2014-06-300.71%
10-Q · filed 2014-11-05
2014-03-310.71%
10-Q · filed 2015-08-14
0.69%
10-Q · filed 2014-05-08
2013-12-310.33%
10-K · filed 2015-03-05
2013-09-300.33%
10-Q/A · filed 2014-09-30
2013-06-300.33%
10-Q · filed 2014-11-05
2012-12-310.31%
10-K · filed 2014-03-06
0.00%
10-K · filed 2013-03-15
2012-09-300.31%
10-Q/A · filed 2014-09-30
2012-06-300.31%
10-Q · filed 2013-08-05
2012-03-310.31%
10-Q · filed 2013-05-14